NCT01428466View on ClinicalTrials.gov

Japanese Phase 1 Study of GSK2585823

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 18, 2010

Primary Completion Date

February 15, 2011

Study Completion Date

February 15, 2011

Conditions
Acne Vulgaris
Interventions
DRUG

GSK2585823

CLDM1%/BPO3%

DRUG

Benzoyl peroxide 3%

Benzoyl peroxide 3%

DRUG

Benzoyl peroxide 5%

Benzoyl peroxide 5%

OTHER

Vehicle

placebo

Trial Locations (1)

170-0003

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY